These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5843266)

  • 1. An androgen-dependent mouse mammary tumor.
    Minesita T; Yamaguchi K
    Cancer Res; 1965 Aug; 25(7):1168-75. PubMed ID: 5843266
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 3. Pituitary function and hormonal therapy of experimental breast cancer.
    Kim U
    Cancer Res; 1965 Aug; 25(7):1146-61. PubMed ID: 5843265
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical studies of hormone-responsive mammary tumors.
    Hilf R
    Cancer Res; 1968 Sep; 28(9):1888-90. PubMed ID: 5676740
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of adjuvant endocrine and adjuvant chemoendocrine therapies on metastasis of androgen-dependent Shionogi carcinoma 115.
    Yoshikawa T; Kitamura Y; Uchida N; Yamaguchi K; Matsumoto K
    Cancer Res; 1983 Oct; 43(10):4525-9. PubMed ID: 6883315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of time of castration and tumour volume on time to androgen-independent recurrence in Shionogi tumours.
    So AI; Bowden M; Gleave M
    BJU Int; 2004 Apr; 93(6):845-50. PubMed ID: 15050003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.
    Kitamura Y; Uchida N; Hayata I; Yamaguchi K; Okamoto S; Narita N; Matsumoto K
    Cancer Res; 1980 Dec; 40(12):4781-5. PubMed ID: 7438110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model.
    Miyake H; Tolcher A; Gleave ME
    Cancer Res; 1999 Aug; 59(16):4030-4. PubMed ID: 10463603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of endocrine organ ablation on the growth and biochemical responses of the R3230AC mammary tumor to hormonal treatment.
    Hilf R; Michel I; Bell C; Carrington MJ
    Cancer Res; 1966 Jul; 26(7):1365-70. PubMed ID: 5911576
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K
    Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115.
    Seike H; Takeuchi M; Kitamura Y; Sato B; Yamaguchi K; Matsumoto K
    Anticancer Res; 1983; 3(1):35-9. PubMed ID: 6830149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
    Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
    Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo.
    Tanaka A; Hasegawa Y; Hakamata Y; Kamiakito T; Kuriki K; Yoshida H; Fukayama M
    J Cell Physiol; 2001 Aug; 188(2):194-200. PubMed ID: 11424086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H; Pollak M; Gleave ME
    Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
    Ip MM; Milholland RJ; Kim U; Rosen F
    J Natl Cancer Inst; 1982 Sep; 69(3):673-81. PubMed ID: 6955558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice.
    Medina D; Butel JS; Socher SH; Miller FL
    Cancer Res; 1980 Feb; 40(2):368-73. PubMed ID: 6243251
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
    Briand P
    Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the anti-tumor effect of complicated PDI(2-chlorethyl) aminophenylacetic acid esters with estrogens].
    Larionov LF; Sof'ina ZP; Lagova ND; Shkodinskaia EN; Iaguzhinskaia VP; Vasina OS
    Vopr Onkol; 1968; 14(11):61-4. PubMed ID: 5729488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.